Mesothelioma Cancer

Malignant mesothelioma detection, like other cancers, can be accomplished with imaging equipment, such as x-ray machines. But once detected, mesothelioma diagnosis is difficult for a number of reasons. First, there is a very extended time period between the exposure to asbestos and the onset of the disease, sometimes as long as 50 to 60 years. Patients would often not think to tell their doctors about working in an asbestos-related job many years earlier.

Second, the typical symptoms of mesothelioma, shortness of breath and coughing, are also symptoms of many other types of lung problems, both cancerous and non-cancerous. Thus, just because a person has these symptoms, it does not in any way provide a mesothelioma diagnosis.
Third, many types of tumors can exist in the serous cavities that are not mesothelioma. These other types of tumors can be non cancerous, or benign, that originate in the tissues of the serous membranes, other than the mesothelium. Or they can be tumors that have migrated from other organs with cancerous growths due to metastases.
Mesothelioma and Imaging Technologies
X-rays and other types of imaging technologies can be used to detect tumors or effusion (build up of fluid) in the body, including mesothelioma detection. A growth in the chest cavity will show up in an X-ray or MRI analysis. But these devices cannot directly determine the type of cancer or provide a mesothelioma diagnosis. They cannot determine whether the tumor is mesothelioma or originates from some other source.

Positron emission tomography (PET) is a type of diagnostic imaging scan that is used for malignant mesothelioma detection. PET scans use the emission of positrons (tiny particles that are emitted from radioactive substances) for the purpose of radiation detection.
Some medical professionals are of the impression that PET scans are the most effective method through which to definitively verify a case of mesothelioma. While they believe that standard imaging techniques like x-rays and MRIs should continue to play a role in diagnosing the disease, it is felt that positron emission tomography is becoming an increasingly valuable tool in the staging and typing of the latent asbestos cancer.
Diagnostic Surgery – Biopsy
To provide a mesothelioma diagnosis, a biopsy is needed. This biopsy then undergoes what is called diagnostic histopathology. Histopathology is a technique where the cells from the tumor are viewed under a high-powered microscope, or electron microscopy. Electron microscopy is considered the gold standard for evaluating tumor material from a biopsy. It is a highly advanced microscope that allows viewing of the tiniest elements of cell tissue.
For mesothelioma diagnosis, a pathologist (a doctor who specializes in disease detection) places the tumor cells in the electron microscope and then views the structure of the individual cells. The mesothelioma cells have a specific shape and pattern, and this allows them to be identified by a very keen pathologist. But mesothelioma cells also look similar to other types of cancer cells, such as adenocarcinoma cells, and this can make the pathologist’s job very difficult. Even with the electron microscope, the different types of mesothelioma cells can be hard to recognize. The three types of cells are epithelioid mesothelioma cancer cells, which are tubular in shape, sarcomatoid mesothelioma cancer cells, which are oval and irregularly shaped, and biphasic mesothelioma cancer cells, which are a combination of shapes. These cells can be confused with other types of cancer cells.
New Methods For Mesothelioma Detection
Due to this diagnostic confusion, much research is underway to find new methods for diagnosis. One method is to evaluate the types of compounds generated by the mesothelioma cancer cells. This is called histochemistry. Histochemical reactions have long been used to distinguish between mesothelial and other types of tumor cells. For example, mesothelial cells are known to produce specific types of carbohydrate compounds. Unfortunately, other types of cells in the body also produce these compounds.
Immunochemistry is also being used to detect mesothelioma. This area of study evaluates the presence of antibodies in the body. Certain types of antibodies are known to be associated with certain types of cancer. But mesothelial cells have no specific types of antibodies that can provide a “positive” marker. Consequently, immunochemistry allows the doctor to “eliminate” the other cancers, but does not indicate the presence of mesothelioma. These techniques offer insight into the disease and may help eliminate other diseases, but none can directly detect mesothelioma.
New Blood Tests for Mesothelioma Detection
SMR Protein: Recently, because of the difficulty in diagnosing malignant mesothelioma, research has concentrated on finding new ways to detect the presence of the disease. Researchers in Australia have found that a certain protein, called SMR or Soluble Mesothelin Related protein, is elevated in patients with mesothelioma. These researchers have suggested that a test for the presence of SMR in the blood could represent a useful marker for the diagnosis and disease progression. They feel that such a diagnosis tool could lead to earlier detection, and thus more effective treatment.
One of the most striking findings of their research was that several asbestos-exposed persons who tested positive for SMR were diagnosed with mesothelioma within three years. They suggested that evaluation of SMR may help to identify persons at risk for this deadly disease. Also, they found that SMR levels increase as mesothelioma progresses, suggesting that SMR evaluation could be used to track the progression of the disease and the effectiveness of treatment
Osteopontin Glycoprotein: In an effort to produce the first early-detection test to screen for malignant mesothelioma, researchers at Wayne State University have been studying the possible link between mesothelioma development and levels of a glycoprotein called osteopontin. Early clinical study findings of 190 patients have demonstrated a link between high levels of osteopontin and the development of malignant pleural mesothelioma.
Although the results are being viewed as preliminary, there is a great deal of excitement surrounding the potential of a blood test capable of screening for mesothelioma in its earliest stages. While there is no known cure for malignant mesothelioma, research is ongoing and certain successes have already been realized in terms of extending survival time beyond the one to two year post-diagnosis average. It is hoped that if mesothelioma specialists have more time through which to conduct treatment on a lesser developed form of the asbestos cancer, the greater a patient’s chance at potential survival.
Despite the fact that the preliminary results of the osteopontin blood test clinical trial have been met with some controversy, the National Cancer Institute (NCI) continues to sponsor additional study.
Tell Your Doctor About Asbestos Exposure
If you or a loved one has been exposed to asbestos, even if it was in the distant past, it is very important that you inform your doctor. One reason why mesothelioma is such a deadly disease is that it is detected late in the disease process. If your doctor knows of the exposure, he or she may be more aware of your symptoms or other health issues that could be used for early detection.

Tags: area, Art, articl, Asbestos, Asbestos Cancer, asbestos exposure, Australia, biopsy, blood, cancer, cancer cells, cancers, case, cavities, cavity, cells, certain types of cancer, chemical, chemical reactions, chest, chest cavity, clinical trial, confusion, cough, deadly disease, diagnosis, diagnostic surgery, dis, disease, diseases, doctor who, doctors, ears, emission tomography, fact, form, gene, growth, Health, imaging, Important, job, love, Lung, lung problems, Malignant Mesothelioma, malignant pleural mesothelioma, man, Mesothelioma, Mesothelioma Cancer, mesothelioma diagnosis, metastases, microscope, mri, national cancer institute, nci, organs, part, particles, patient, place, pleura, pleural, Pleural Mesothelioma, presence, profession, radiati, radiation, rate, ray machine, Research, result, risk, shortness of breath, stage, successes, Surgery, Survival, symptoms of mesothelioma, test, time, tissues, tomography, Treatment, tumor, tumor cells, tumors, type, type of cancer, types of cancer, US, year

The chemotherapy is the use of drugs for the treatment of patients with cancer. These drugs can be used to the size of the tumors before surgery, or as a primary treatment, if the patient is not a candidate for the surgery. The chemotherapy is effective, because the toxic substances have the greatest effect on the fast-growing cells, such as found in the tumors. Normal, the fast-growing cells, like the cells of the bone marrow, the digestive tract, mouth, stomach, and the hair (discernible hair loss caused by chemotherapy patients) can also be performed. Common side effects of chemotherapy, anemia, nausea, vomiting, fatigue, diarrhea, skin rashes and pain.

Alimta, in combination with the standard drug, cisplatin, is the first and only one in the chemotherapy have proved effective in extending the lives of patients with malignant pleural mesothelioma when surgery is not an option. The clinical studies have shown that the average life expectancy of patients has been postponed by nearly 30% compared to the cisplatin alone. 50.3% of patients, the association has a year later, while cisplatin alone, the survival rate of 38% in a year. Alimta-cisplatin is the only therapy, must by the FDA for the treatment of non-surgical malignant pleural mesothelioma.

Treatment with ALIMTA

ALIMTA is a medicine by a doctor. Frequency and dosage of the treatment depends on the individual case. Alimta patients are required to take the folic acid, vitamin 5 to 7 days prior to the treatment to help reduce the side effects. The folic acid dose depends on the type and the advice of a doctor, but standard doses between 350 and 1000 micrograms (the amount by a multi-vitamin pill). The patients are usually required to stop taking folic acid for 21 days after the last round of Alimta.

A doctor is also an injection Muskelaufbau vitamin B-12 during the week before the treatment. Regular B-12 shots continued to be used for the treatment and can only be granted, probably on the same day as Alimta.

An oral steroid known as dexamethasone may reduce, skin rashes and other side effects. Most diets Alimta includes a double dose daily on the eve of the day, and day after treatment. Patients are asked not to take anti-inflammatory medicines like ibuprofen and forgo alcohol.

The adverse effects of Alimta

Vitamin B 12 and folic acid can usually reduce the side effects of treatment Alimta, but it can cause serious side effects, which may require the reduction, suspension or termination of therapy. Patients can see the side effects in a category known by the name of the patient estimated toxicities. Some of the most common of these side effects are top. If a patient from the experience that these side effects or other unpleasant reactions, he or she must inform the doctor.

Paper toxicities are the type of adverse effects that the patient can not be in the loop. These side effects may also make changes in the cells, blood or asymptotically deterioration of the internal organs. Alimta treatment includes regular laboratory tests to monitor the possibility of these side effects.

Tags: alimta, average life expectancy, bone marrow, cancer drugs, chemotherapy, chemotherapy patients, digestive tract, drug cisplatin, folic acid, Malignant Mesothelioma, malignant pleural mesothelioma, Mesothelioma Treatment, micrograms, multi vitamin, skin rashes, survival rate, toxic substances, vitamin b 12, vitamin pill

Australia has the highest per capita cases of mesothelioma. The worst, say the experts, is still to come, most cases of mesothelioma in Australia are on the type of malignant pleural mesothelioma. Most of the cases have the disease because of asbestos exposure. If the asbestos fibers or asbestos dust is inhaled through the nose, it’s going to the respiratory system. Can he is in the lungs. The lungs have a coating called mésothélium as fodder. This surface is associated with asbestos fibers, it begins, in a funny way.

It starts quickly and divided it also begins a better quality of life. This leads to tumors in the lungs, and this condition is pleural mesothelioma. That may cause cancer cells (malignant pleural mesothelioma), or non-malignant (benign pleural mesothelioma). Australia has a great many cases of malignant pleural mesothelioma. It is a very terrible and no treatment. Because the symptoms of the disease such as fever, cough, chest pain, etc., are often associated with other diseases such as pneumonia, it is difficult to properly diagnose the disease.

It is often diagnosed only the last stages of cancer. The patient is alive, barely a year after the diagnosis. Also, the latency period of this disease is very long. The period of latency is the time between exposure to asbestos fibers and the occurrence of this disease. Because of the long latency period of 20 to 30 years, repeatedly this disease is not discussed how to asbestos. Australia has about 16 cases per million population of adults covered by the mesothelioma every year. The number of cases of mesothelioma is substantially higher among men than among women. About 600 cases of mesothelioma will be a year in Australia. It is envisaged that in the next 10-15 years, roughly about 13000 cases of mesothelioma are registered.

There is a group at high risk in Australia. The following persons in Australia appears to be more than mesothelioma compared to the rest of the population:

• City residents
• Builders workers in the construction industry
• The workers in the shipbuilding and shipyard
• The employees of the railway
• asbestos workers in the factory
• Performance of the employees of the chain.

Although Australia has a huge impact of the death of mesothelioma, from Australia to the world, a pioneer in many of the medical research in mesothelioma. He found a new method of treatment, promises to the mortality rate. Since there is no cure for this disease, it’s better if they detected early. The usual procedure for the treatment like chemotherapy and surgery will not work in the last stages of cancer, it is therefore better if the disease is detected early. Australian researchers have developed a new screening test that can help to identify malignant pleural mesothelioma nature. This can be in the group with a high risk to know, the first evidence of malignant pleural mesothelioma. The earlier the disease is detected, the better the chances of survival of the patient. Australian researchers have more and more research in the field of medical mesothelioma. Australia is a true pioneer in research mesothelioma. He is a leader and an example for all other countries. Although Australia has so much to do to push forward the research mesothelioma, and the future of Australia is dark.

It is expected that the number of deaths in Australia mesothelioma will continue to rise until the year 2020. It is envisaged that the deaths from mesothelioma, the ever to a standstill. This is mainly due to the long latency period of mesothelioma. So, even after all types of asbestos are banned completely, the effects of asbestos exposure can be felt up to 20 to 30 years later. One of the advantages for the whole research is that the chances of survival are increased, the patients with mesothelioma.

Also, the life expectancy of the patient after the detection of the disease has increased. Previously, the patient hardly a year to live. But today, as an early diagnosis, which has significantly increased. Australia should continue to intensify the research on mesothelioma for the common good. He should endeavour to progress in medical science, with new innovations in the treatment of Mesothelioms. All other countries should help to support actively the efforts of Australia. In Australia should also be made available to the outcome of his efforts for the whole wide world.

Tags: asbestos dust, asbestos exposure, asbestos fibers, cancer cells, chest pain, city residents, cough, fodder, funny way, high risk, last stages of cancer, latency period, malignant pleural mesothelioma, occurrence, pneumonia, population city, quality of life, respiratory system, stages of cancer, tumors in the lungs

The earlier the symptoms of malignant pleural mesothelioma are very similar to those with other lung diseases such as pneumonia or lung cancer. The symptoms tend, even on very gradually, and therefore can long remain undetected for some time. Shortness is one of the earliest and the typical symptoms of pleural mesothelioma. That can, as a recent onset of shortness of breath or an increased shortness of breath. Shortness can be an accumulation of fluids (pleural effusion), in the space around the lung. This accumulation of fluid at regular intervals can be removed to facilitate breathing. Some substances may also in the space between the membranes pleurales where fluid collects. These substances lead to an inflammatory response in the pleurales membranes, which are merging, thus preventing the training and the collection of more liquid.

The pleural thickening of the membranes by the growth of cancer cells are also the lung function and contributes to the shortness. Sometimes the thickening of the tissue can order the removal of the operation again some lung function. The process is known as referral décortication or pleurectomy.

Mésothéliome clever tend to be fairly quickly to other parts of the body, and this difference may be additional symptoms. If pleural mesothelioma on the chest wall and other tissues of the chest, it can cause severe pain. Even before the cancer, the pain in the chest, particularly in the lower part of the chest and on the side, can be experienced. Chest pain gradually growing bigger problem than the cancer grows. A pain can be processed, with a strong relief of pain with drugs and radiation therapy. If pleural mesothelioma on the lung, the symptoms that are usually having lung cancer, such as cough and hoarseness blood, can be present.

As with other types of cancer, the effect of pleural mesothelioma is very common. The increase in the metabolism of cancer cells, which by the results of fever, weight loss and fatigue.

Tags: accumulation, cancer cells, chest pain, chest wall, cough, hoarseness, inflammatory response, Lung Cancer, lung diseases, lung function, malignant pleural mesothelioma, Mesothelioma Symptoms, pleural effusion, pleurectomy, pneumonia, radiation therapy, severe pain, shortness of breath, types of cancer, typical symptoms